ADCOCK INGRAM HOLDINGS LIMITED - Update on the acquisition of certain assets of Cosme Farma Laboratories Limited (India)

Update on the acquisition of certain assets of Cosme Farma Laboratories Limited (India)

Adcock Ingram Holdings Limited 
(Registration number 2007/016236/06) 
(Incorporated in the Republic of South Africa) 
Share code: AIP 
ISIN: ZAE000123436 
("Adcock Ingram") 
 
 
UPDATE ON THE ACQUISITION OF CERTAIN ASSETS OF COSME FARMA LABORATORIES LIMITED (INDIA) 
 
Shareholders are referred to the announcement released by Adcock Ingram on SENS on 10 July 2012, relating 
to the acquisition by Adcock Ingram through its wholly owned subsidiary, Adcock Ingram Healthcare Private 
Limited, of certain assets of Cosme Farma Laboratories Limited (“Cosme”) (“the Transaction”) and are advised 
that  the  regulatory  approvals  in  India  are  still  in  process.  The  previously  anticipated  closing  date  for  the 
Transaction, being 31 October 2012, has not been achieved.  In terms of an extension agreement entered into 
between  Adcock  Ingram  and  Cosme  the  closing  date  for  the  Transaction  has  been  extended  to  31 January 
2013. 
 
Midrand 
01 November 2012 
 
Sponsor 
Deutsche Securities (SA) Proprietary Limited 
 

Date: 01/11/2012 10:16:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.